BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4043057)

  • 1. Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis.
    Hoeprich PD; Merry JM
    Eur J Clin Microbiol; 1985 Aug; 4(4):400-3. PubMed ID: 4043057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A direct comparison of oral treatments with BAY-n-7133, BAY-1-9139 and ketoconazole in experimental murine coccidioidomycosis.
    Levine HB
    Sabouraudia; 1984; 22(1):37-46. PubMed ID: 6322362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of the triazole Bay R 3783 in mouse models of coccidioidomycosis, blastomycosis, and histoplasmosis.
    Pappagianis D; Zimmer BL; Theodoropoulos G; Plempel M; Hector RF
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1132-8. PubMed ID: 2393272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).
    Graybill JR; Sun SH; Ahrens J
    J Med Vet Mycol; 1986 Apr; 24(2):113-9. PubMed ID: 3014105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azole antifungal drugs in treatment of coccidioidomycosis.
    Graybill JR
    Semin Respir Infect; 1986 Mar; 1(1):53-60. PubMed ID: 3317599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
    Clemons KV; Homola ME; Stevens DA
    Antimicrob Agents Chemother; 1995 May; 39(5):1169-72. PubMed ID: 7625808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro studies with four new antifungal agents: BAY n 7133, bifonazole (BAY h 4502), ICI 153,066 and Ro 14-4767/002.
    Shadomy S; Espinel-Ingroff A; Kerkering TM
    Sabouraudia; 1984; 22(1):7-15. PubMed ID: 6322364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacies of two novel azole derivatives each containing a morpholine ring, UR-9746 and UR-9751, against systemic murine coccidioidomycosis.
    Clemons KV; Stevens DA
    Antimicrob Agents Chemother; 1997 Jan; 41(1):200-3. PubMed ID: 8980782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.
    Lutz JE; Clemons KV; Aristizabal BH; Stevens DA
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1558-61. PubMed ID: 9210684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketoconazole in early and late murine coccidioidomycosis.
    Levine HB; Cobb JM
    Rev Infect Dis; 1980; 2(4):546-50. PubMed ID: 6255530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of cilofungin against Coccidioides immitis: differential in vitro effects on mycelia and spherules correlated with in vivo studies.
    Galgiani JN; Sun SH; Clemons KV; Stevens DA
    J Infect Dis; 1990 Oct; 162(4):944-8. PubMed ID: 2144867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral therapy for experimental coccidioidomycosis with R41 400 (ketoconazole), a new imidazole.
    Levine HB; Cobb JM
    Am Rev Respir Dis; 1978 Oct; 118(4):715-21. PubMed ID: 707893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo activities of posaconazole against Coccidioides immitis.
    González GM; Tijerina R; Najvar LK; Bocanegra R; Rinaldi M; Loebenberg D; Graybill JR
    Antimicrob Agents Chemother; 2002 May; 46(5):1352-6. PubMed ID: 11959568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis.
    Sobel JD; Muller G
    Antimicrob Agents Chemother; 1983 Sep; 24(3):434-6. PubMed ID: 6314893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis.
    Wiederhold NP; Najvar LK; Jaramillo R; Olivo M; Birch M; Law D; Rex JH; Catano G; Patterson TF
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of the triazole D0870 in the treatment of experimental systemic coccidioidomycosis.
    Clemons KV; Stevens DA
    J Med Vet Mycol; 1994; 32(4):323-6. PubMed ID: 7983578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis.
    Lefler E; Brummer E; Perlman AM; Stevens DA
    Antimicrob Agents Chemother; 1985 Mar; 27(3):363-6. PubMed ID: 3994350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketoconazole for treatment of disseminated coccidioidomycosis.
    Catanzaro A; Einstein H; Levine B; Ross JB; Schillaci R; Fierer J; Friedman PJ
    Ann Intern Med; 1982 Apr; 96(4):436-40. PubMed ID: 6279004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miconazole therapy for coccidioidomycosis.
    Hoeprich PD; Goldstein E
    JAMA; 1974 Nov; 230(8):1153-7. PubMed ID: 4479523
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antifungal action of Bay b 5097 in experimental coccidioidomycosis in mice].
    Vanbreuseghem R; De Vroey C; Takashio M; Swinne-Desgain D
    Mykosen; 1975 Jan; 18(1):25-8. PubMed ID: 1117888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.